The Procter & Gamble Company (NYSE:PG) is Broderick Brian C’s 9th Largest Position

Broderick Brian C cut its holdings in The Procter & Gamble Company (NYSE:PG) by 0.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 100,410 shares of the company’s stock after selling 328 shares during the period. Procter & Gamble accounts for 3.4% of Broderick Brian C’s holdings, making the stock its 9th biggest holding. Broderick Brian C’s holdings in Procter & Gamble were worth $17,391,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Concurrent Investment Advisors LLC grew its stake in Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares in the last quarter. Radnor Capital Management LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at about $5,705,000. Welch Group LLC grew its position in shares of Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after purchasing an additional 2,990 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares during the last quarter. Finally, Quintet Private Bank Europe S.A. lifted its position in shares of Procter & Gamble by 15.0% in the third quarter. Quintet Private Bank Europe S.A. now owns 426,820 shares of the company’s stock worth $73,925,000 after buying an additional 55,620 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. TD Cowen assumed coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target on the stock. Piper Sandler started coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. DA Davidson lifted their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research note on Monday, October 21st. Finally, JPMorgan Chase & Co. upped their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $177.00.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $167.08 on Friday. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a market capitalization of $393.48 billion, a PE ratio of 28.81, a price-to-earnings-growth ratio of 3.60 and a beta of 0.42. The stock’s fifty day moving average is $170.61 and its two-hundred day moving average is $168.28. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the prior year, the business posted $1.83 earnings per share. As a group, analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.41%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is 69.48%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the company’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the sale, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. This represents a 2.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 313,597 shares of company stock valued at $53,268,499. Company insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.